Scholarlink

Purpose <p>To compare the clinical outcomes of “Single Surgeon” and “Single Site” total thoracoscopic surgery with multi-portal video-assisted thoracic surgery (M-VATS) in the treatment of paediatric extralobar sequestration (ELS), and to evaluate its safety and feasibility in routine practice.</p> Methods <p>We retrospectively analysed 51 paediatric ELS cases treated thoracoscopically at our institution from January 2020 to March 2025. Patients were grouped by surgical approach: 18 underwent single-site thoracoscopy, and 33 underwent M-VATS. Clinical parameters were compared between groups.</p> Results <p>Compared to M-VATS, the single-site group showed significantly reduced operative time (<i>P</i> = 0.02), blood loss (<i>P</i> &lt; 0.01), hospital stay (<i>P</i> &lt; 0.01), and expenses (<i>P</i> &lt; 0.01). No bronchopleural fistulas, postoperative pneumonia, or conversions to open surgery occurred in either group.</p> Conclusions <p>“Single Surgeon” and “Single Site” thoracoscopic surgery offers distinct advantages, including minimized incisions, faster recovery, and reduced resource consumption, aligning with modern minimally invasive and enhanced recovery practices. The technique demonstrates safety, efficiency, and cost-effectiveness, supporting its broader clinical adoption.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

"Single surgeon" and "single site" total thoracoscopic surgery for paediatric extralobular pulmonary sequestration

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月2日

查看全文
  • Rui Guo,
  • Yunpeng Zhai,
  • Huashan Zhao,
  • Gang Shen,
  • Sai Huang,
  • Longfei Lv,
  • Honghao Song,
  • Shisong Zhang

摘要

Purpose

To compare the clinical outcomes of “Single Surgeon” and “Single Site” total thoracoscopic surgery with multi-portal video-assisted thoracic surgery (M-VATS) in the treatment of paediatric extralobar sequestration (ELS), and to evaluate its safety and feasibility in routine practice.

Methods

We retrospectively analysed 51 paediatric ELS cases treated thoracoscopically at our institution from January 2020 to March 2025. Patients were grouped by surgical approach: 18 underwent single-site thoracoscopy, and 33 underwent M-VATS. Clinical parameters were compared between groups.

Results

Compared to M-VATS, the single-site group showed significantly reduced operative time (P = 0.02), blood loss (P < 0.01), hospital stay (P < 0.01), and expenses (P < 0.01). No bronchopleural fistulas, postoperative pneumonia, or conversions to open surgery occurred in either group.

Conclusions

“Single Surgeon” and “Single Site” thoracoscopic surgery offers distinct advantages, including minimized incisions, faster recovery, and reduced resource consumption, aligning with modern minimally invasive and enhanced recovery practices. The technique demonstrates safety, efficiency, and cost-effectiveness, supporting its broader clinical adoption.